A Multicenter Survey of Heparin Prophylaxis Practice in Pediatric Critical Care

Abstract

Heparin prophylaxis (HP) is commonly used for prevention of central venous catheter (CVC)-related complications among pediatric intensivists, yet efficacy of this therapy is unknown. We conducted a survey of pediatric intensivists and their experiences with HP. A total of 96 responses were received. Almost half of the respondents regularly used HP in patients with CVCs, yet most were unsure of its benefit. The majority of respondents claimed to experience no adverse effects; the complications that were reported to occur were related to bleeding or suspected heparin-induced thrombocytopenia (HIT). Overall, participants felt CVC-associated HP was safe in pediatric critical illness, while acknowledging the paucity of compelling data.

Keywords

pediatric critical illness heparin prophylaxis thrombosis central venous catheters

Get full access to this article

View all access options for this article.

References

Klerk

Smorenburg

Buller

. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch Intern Med. 2003;163(16):1913–1921.

Andrew

David

Adams

. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood. 1994;83(5):1251–1257.

Massicotte

Julian

Gent

. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res. 2003;109(2-3):101–108.

Beck

Dubois

Grignon

Lacroix

David

. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. J Pediatr. 1998;133(2):237–241.

Kamala

Boo

Cheah

Birinder

. Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates. Acta Paediatr. 2002;91(12):1350–1356.

Salonvaara

Riikonen

Kekomaki

Heinonen

. Clinically symptomatic central venous catheter-related deep venous thrombosis in newborns. Acta Paediatr. 1999;88(6):642–646.

Abdelkefi

Torjman

Ladeb

. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. J Clin Oncol. 2005;23(31):7864–7870.

Bailey

. Reduction of catheter-associated sepsis in parenteral nutrition using low-dose intravenous heparin. Br Med J. 1979;1(6179):1671–1673.

Brismar

Hardstedt

Jacobson

Kager

Malmborg

. Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Arch Surg. 1982;117(9):1196–1199.

10.

Randolph

Cook

Gonzales

Andrew

. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomized controlled trials. Br Med J. 1998;316(7136):969–975.

11.

de Neef

Heijboer

van Woensel

de Haan

. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatr Hematol Oncol. 2002;19(8):553–560.

12.

Slamon

Krueger

Edelson

Glutting

Rittenhouse

. A retrospective study of the factors associated with hypercoagulability in the pediatric patients at a tertiary care children's hospital. Pediatr Crit Care Med. 2008;9(5):511–516.

13.

Shah

Kalyn

Satodia

. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study. Pediatrics. 2007;119(1):e284–e291.